QuidelOrtho Corporation (LON:0A55)
London
· Delayed Price · Currency is GBP · Price in USD 43.50
-0.14 (-0.31%)
At close: Jan 31, 2025
QuidelOrtho Employees
QuidelOrtho had 6,600 employees as of December 29, 2024. The number of employees decreased by 500 or -7.04% compared to the previous year.
Employees
6,600
Change (1Y)
-500
Growth (1Y)
-7.04%
Revenue / Employee
323.58K GBP
Profits / Employee
-41.98K GBP
Market Cap
1.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 6,600 | -500 | -7.04% |
| Dec 31, 2023 | 7,100 | 100 | 1.43% |
| Jan 1, 2023 | 7,000 | 5,400 | 337.50% |
| Jan 2, 2022 | 1,600 | 230 | 16.79% |
| Jan 3, 2021 | 1,370 | 120 | 9.60% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
QuidelOrtho News
- 7 days ago - QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs - PRNewsWire
- 5 weeks ago - QuidelOrtho to discontinue Savanna platform development - Seeking Alpha
- 5 weeks ago - QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics - PRNewsWire
- 7 weeks ago - QuidelOrtho to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - Benzinga
- 2 months ago - SA analyst downgrades: QDEL, AMCX, PLYM, DAY - Seeking Alpha
- 2 months ago - QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade) - Seeking Alpha
- 2 months ago - Quidelortho sees $30M-$40M tariff impact offset, maintains 2025 guidance - Seeking Alpha